| Literature DB >> 35300082 |
Hanan Almolhim1, Sha Ding1, Joshua H Butler2, Emily K Bremers2, Grant J Butschek2, Carla Slebodnick1, Emilio F Merino2, Zaira Rizopoulos3, Maxim Totrov4, Maria B Cassera2, Paul R Carlier1.
Abstract
The tetrahydro-β-carboline scaffold has proven fertile ground for the discovery of antimalarial agents (e.g., MMV008138 (1) and cipargamin (2)). Similarity searching of a publicly disclosed collection of antimalarial hits for molecules resembling 1 drew our attention to N2-acyl tetrahydro-β-carboline GNF-Pf-5009 ((±)-3b). Compound purchase, "analog by catalog", and independent synthesis of hits indicated the benzofuran-2-yl amide portion was required for in vitro efficacy against P. falciparum. Preparation of pure enantiomers demonstrated the pharmacological superiority of (R)-3b. Synthesis and evaluation of D- and F-ring substitution variants and benzofuran isosteres indicated a clear structure-activity relationship. Ultimately (R)-3b was tested in Plasmodium berghei-infected mice; unfavorable physicochemical properties may be responsible for the lack of oral efficacy.Entities:
Year: 2022 PMID: 35300082 PMCID: PMC8919387 DOI: 10.1021/acsmedchemlett.1c00697
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345